{"resourceType":"Bundle","id":"tests-4bd89ab4-415c-4cca-84c1-0f25968bf4ba-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/4bd89ab4-415c-4cca-84c1-0f25968bf4ba","resource":{"resourceType":"Patient","id":"4bd89ab4-415c-4cca-84c1-0f25968bf4ba","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2054-5","display":"Black or African American","userSelected":true}},{"url":"text","valueString":"Black or African American"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2186-5","display":"Not Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Not Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"62fd10a385b0356a7c285335"}],"name":[{"family":"DenomFail","given":["GleasonBefore1stTxValueGreaterThan6"]}],"gender":"male","birthDate":"1992-09-17"},"request":{"method":"PUT","url":"Patient/4bd89ab4-415c-4cca-84c1-0f25968bf4ba"}},{"fullUrl":"https://madie.cms.gov/Condition/prostate-cancer-a8d8","resource":{"resourceType":"Condition","id":"4994b513-5dfe-4a7b-899b-3a6887403ed3","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"]},"clinicalStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-clinical","code":"active","display":"active","userSelected":true}]},"category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-category","code":"problem-list-item","display":"Problem List Item"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"254900004","display":"Carcinoma of prostate (disorder)","userSelected":true}]},"subject":{"reference":"Patient/4bd89ab4-415c-4cca-84c1-0f25968bf4ba"},"onsetPeriod":{"start":"2018-06-14T08:00:00.000+00:00"}},"request":{"method":"PUT","url":"Condition/4994b513-5dfe-4a7b-899b-3a6887403ed3"}},{"fullUrl":"https://madie.cms.gov/Procedure/prostate-cancer-treatment-a8d9","resource":{"resourceType":"Procedure","id":"308e4b5e-5f6c-4012-afa4-57277aa7eabb","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"]},"extension":[{"url":"http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-recorded","valueDateTime":"2023-02-01T09:00:00.000+00:00"}],"status":"completed","code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"10492003","display":"Radionuclide therapy for glandular suppression (procedure)","userSelected":true}]},"subject":{"reference":"Patient/4bd89ab4-415c-4cca-84c1-0f25968bf4ba"},"performedDateTime":"2025-04-28T08:00:00.000+00:00"},"request":{"method":"PUT","url":"Procedure/308e4b5e-5f6c-4012-afa4-57277aa7eabb"}},{"fullUrl":"https://madie.cms.gov/Observation/prostate-specific-antigen-test-a8db","resource":{"resourceType":"Observation","id":"9fb1aa3d-a815-404a-a363-5db5477b4fb8","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"amended","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"10508-0","display":"Prostate specific Ag [Presence] in Tissue by Immune stain","userSelected":true}]},"subject":{"reference":"Patient/4bd89ab4-415c-4cca-84c1-0f25968bf4ba"},"effectiveDateTime":"2025-02-02T08:00:00.000+00:00","valueQuantity":{"value":5.0,"system":"http://unitsofmeasure.org","code":"ng/mL"}},"request":{"method":"PUT","url":"Observation/9fb1aa3d-a815-404a-a363-5db5477b4fb8"}},{"fullUrl":"https://madie.cms.gov/Observation/gleason-score-in-specimen-qualitative-a8dc","resource":{"resourceType":"Observation","id":"78352ecb-f118-4dd1-a14f-9d0f34bf744c","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","code":"35266-6","display":"Gleason score in Specimen Qualitative","userSelected":true}]},"subject":{"reference":"Patient/4bd89ab4-415c-4cca-84c1-0f25968bf4ba"},"effectiveDateTime":"2025-08-17T08:00:00.000+00:00","valueInteger":5},"request":{"method":"PUT","url":"Observation/78352ecb-f118-4dd1-a14f-9d0f34bf744c"}},{"fullUrl":"https://madie.cms.gov/Observation/tumor-staging-tumor-staging-a8dd","resource":{"resourceType":"Observation","id":"73ab828f-744f-4144-b3e9-00233d8c7613","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"amended","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"254292007","display":"Tumor staging (tumor staging)","userSelected":true}]},"subject":{"reference":"Patient/4bd89ab4-415c-4cca-84c1-0f25968bf4ba"},"effectiveDateTime":"2025-04-27T23:59:00.000+00:00","valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"433351000124101","display":"Neoplasm of prostate primary tumor staging category T1c: Tumor identified by needle biopsy (finding)","userSelected":true}]}},"request":{"method":"PUT","url":"Observation/73ab828f-744f-4144-b3e9-00233d8c7613"}},{"fullUrl":"https://madie.cms.gov/Coverage/1","resource":{"resourceType":"Coverage","id":"01279b59-ceb8-44fa-89a6-2528ab9784a1","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"]},"status":"active","beneficiary":{"reference":"Patient/4bd89ab4-415c-4cca-84c1-0f25968bf4ba"},"payor":[{"reference":"Organization/024e2731-b045-43bf-80d2-684774c5b51c"}]},"request":{"method":"PUT","url":"Coverage/01279b59-ceb8-44fa-89a6-2528ab9784a1"}},{"fullUrl":"https://madie.cms.gov/Organization/123456","resource":{"resourceType":"Organization","id":"024e2731-b045-43bf-80d2-684774c5b51c","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-organization"]},"identifier":[{"use":"temp","system":"urn:oid:2.16.840.1.113883.4.4","value":"21-3259825"}],"active":true,"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/organization-type","code":"pay","display":"Payer"}]}],"name":"Blue Cross Blue Shield of Texas","telecom":[{"system":"phone","value":"(+1) 972-766-6900"}],"address":[{"use":"billing","type":"postal","line":["P.O. Box 660044"],"city":"Dallas","state":"TX","postalCode":"75266-0044","country":"USA"}]},"request":{"method":"PUT","url":"Organization/024e2731-b045-43bf-80d2-684774c5b51c"}},{"fullUrl":"https://madie.cms.gov/Practitioner/practitioner-123456","resource":{"resourceType":"Practitioner","id":"d939f3ba-71ab-4a38-8354-c42bf0494f76","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-practitioner"]},"identifier":[{"system":"http://hl7.org/fhir/sid/us-npi","value":"123456"}],"name":[{"family":"Evil","prefix":["Dr"]}]},"request":{"method":"PUT","url":"Practitioner/d939f3ba-71ab-4a38-8354-c42bf0494f76"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/41a8de99-b83b-4033-a6cf-a63e3ddfcbc3","resource":{"resourceType":"MeasureReport","id":"41a8de99-b83b-4033-a6cf-a63e3ddfcbc3","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"099133da-e018-4273-9454-3fad76fd1b2e-parameters","parameter":[{"name":"subject","valueString":"4bd89ab4-415c-4cca-84c1-0f25968bf4ba"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#099133da-e018-4273-9454-3fad76fd1b2e-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Prostate Ca Diagnosis but does not meet Gleason. Meets tumor staging. first treatment, and  PSA.  Gleason is before 1st cancer treatment.  Value >  6.\n"}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/ProstateCaAvoidanceBoneScanOveruseFHIR","period":{"start":"2025-01-01","end":"2025-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exception","display":"Denominator Exception"}]},"count":0}]}]},"request":{"method":"PUT","url":"MeasureReport/41a8de99-b83b-4033-a6cf-a63e3ddfcbc3"}}]}